Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk.
Carcinoma
/ genetics
Cross-Sectional Studies
Female
Genetic Testing
/ methods
Health Knowledge, Attitudes, Practice
Health Personnel
/ psychology
Humans
Male
Pancreatic Neoplasms
/ genetics
Practice Guidelines as Topic
/ standards
Practice Patterns, Physicians'
/ standards
Referral and Consultation
/ statistics & numerical data
Risk Assessment
/ standards
Risk Factors
Surveys and Questionnaires
Health care provider perspective
Inherited risk
Pancreatic cancer
Qualitative research
Journal
Journal of cancer education : the official journal of the American Association for Cancer Education
ISSN: 1543-0154
Titre abrégé: J Cancer Educ
Pays: England
ID NLM: 8610343
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
9
11
2019
medline:
15
12
2020
entrez:
9
11
2019
Statut:
ppublish
Résumé
Recent national guidelines recommend genetic risk assessment for all patients diagnosed with pancreatic cancer, yet individuals with pancreatic cancer obtain genetic testing at suboptimal rates. Both patient and provider factors play a role in adherence to genetic testing recommendations. The purpose of this study was to understand health care provider perspectives of caring for patients with inherited pancreatic cancer risk. The study was a cross-sectional mixed method study utilizing a qualitative interview and a survey. The study sample included health care providers who provide care for patients with pancreatic cancer or inherited risk. Qualitative data were analyzed using content analysis, while quantitative data were summarized using descriptive statistics. Thirty participants had complete interview data and 29 completed a survey. The sample was comprised of physicians (n = 17), genetic counselors (n = 6), nurses (n = 3), and social workers (n = 3). Respondents were less confident in their ability to identify patients with inherited pancreatic cancer risk compared with other hereditary cancer syndromes. Several challenges were identified including the pancreatic cancer illness trajectory; lack of evidence-based practice guidelines; difficulty interpreting genetic test results; and difficulty following up on referrals. Participants perceived a lack of educational resources for patients with inherited pancreatic cancer risk. Health care providers who care for individuals with inherited pancreatic cancer risk face challenges that are distinct from those encountered during the care of individuals for other hereditary cancers. There is a need for additional resources at the patient-, provider-, and system-level.
Identifiants
pubmed: 31701425
doi: 10.1007/s13187-019-01623-1
pii: 10.1007/s13187-019-01623-1
pmc: PMC7057412
mid: NIHMS1546933
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
194-203Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR001100
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002542
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Gynecol Oncol. 2019 Apr;153(1):108-115
pubmed: 30638766
Cancer Res. 2004 Apr 1;64(7):2634-8
pubmed: 15059921
Genet Med. 2017 Apr;19(4):448-456
pubmed: 27684037
J Natl Cancer Inst. 2018 Oct 1;110(10):1067-1074
pubmed: 29506128
Psychooncology. 2018 Jul;27(7):1711-1718
pubmed: 29570238
Gynecol Oncol. 2015 Jul;138(1):109-14
pubmed: 25933682
Fam Cancer. 2016 Apr;15(2):341-50
pubmed: 26590592
Hered Cancer Clin Pract. 2015 May 21;13(1):13
pubmed: 26029287
Gastroenterology. 2018 Sep;155(3):740-751.e2
pubmed: 29803839
Gastroenterol Clin North Am. 2016 Sep;45(3):509-27
pubmed: 27546846
J Clin Oncol. 2016 Aug 20;34(24):2914-24
pubmed: 27325848
J Clin Oncol. 2017 Oct 20;35(30):3382-3390
pubmed: 28767289
Int J Gynecol Cancer. 2014 Jul;24(6):1003-9
pubmed: 24887442
J Clin Oncol. 2017 Dec 1;35(34):3800-3806
pubmed: 28820644
Surg Clin North Am. 2018 Feb;98(1):25-35
pubmed: 29191275
Gut Liver. 2017 Nov 15;11(6):761-770
pubmed: 28609837
Gynecol Oncol. 2018 Jun;149(3):565-569
pubmed: 29653687
Genet Med. 2014 Nov;16(11):830-7
pubmed: 24763289
Cancer. 2017 Jun 15;123(12):2352-2359
pubmed: 28192596
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
J Clin Oncol. 2019 Jan 10;37(2):153-164
pubmed: 30457921
Clin Gastroenterol Hepatol. 2010 Jun;8(6):523-9
pubmed: 20303416
J Genet Couns. 2012 Apr;21(2):305-25
pubmed: 21842318
Am J Clin Oncol. 2016 Aug;39(4):363-7
pubmed: 24710121
Gynecol Oncol. 2017 Aug;146(2):399-404
pubmed: 28610746
Genet Med. 2015 Jun;17(6):485-92
pubmed: 25297947
JAMA. 2018 Jun 19;319(23):2401-2409
pubmed: 29922827
Cancer. 2018 Apr 15;124(8):1691-1700
pubmed: 29360161
Cancers (Basel). 2018 Nov 13;10(11):
pubmed: 30428547
J Clin Oncol. 2017 Jul 10;35(20):2232-2239
pubmed: 28402748
J Clin Oncol. 2015 Jun 1;33(16):1721-8
pubmed: 25918283
Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263
pubmed: 25645574